Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery

@article{Nikolova2014EvaluationOA,
  title={Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery},
  author={Tanja Nikolova and Oleg R Bayev and Natasha Nikolova and Gian Carlo Di Renzo},
  journal={Journal of Perinatal Medicine},
  year={2014},
  volume={42},
  pages={473 - 477}
}
Abstract Objective: The PartoSure™ time-to-delivery (TTD) test (AmniSure International, Boston, MA, USA) is a newly available bedside test for the prediction of time to spontaneous preterm delivery via the detection of placental alpha microglobulin-1. The objective of this study was to determine the efficacy of the test in predicting imminent delivery in 7 or 14 days from the time of testing. Methods: The study population consisted of 101 consecutively recruited pregnant women with singleton… 

Tables from this paper

Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor

PAMG-1 detection by PartoSure is the single best predictor of imminent spontaneous delivery within 7 days compared to fFN and CL, and has the greatest clinical utility in patients with CL between 15 and 35 mm.

Evaluation of placental alpha microglobulin-1(PAMG1) accuracy for prediction of preterm delivery in women with the symptoms of spontaneous preterm labor; a comparison with cervical length and number of contractions

  • M. KashanianNooshin EshraghiM. RahimiN. Sheikhansari
  • Medicine, Biology
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2020
Evaluated the accuracy of the placental alpha microglobulin-1 (PAMG-1) test for identifying women who referred to hospitals with signs of spontaneous preterm labor and ultimately delivered within ≤48 h and ≤7 of testing and ≤37 weeks of gestation and its comparison with cervical length of <25 mm and number of contractions.

Role of cervical length and placental alpha microglobulin-1 to predict preterm birth

  • A. GokceErkan KalafatY. E. SukurO. AltınboğaF. Soylemez
  • Medicine
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2020
PAMG-1 molecule with high NPV and PPV combination will contribute the clinical decision on the population who had preterm labor symptoms and a CL shorter than 25 mm to predict spontaneous preterm birth within seven days.

Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women.

This study does not support introducing placental alpha microglobulin-1 testing into clinical practice just yet, and advocates using the new quantitative fetal fibronectin test combined with cervical length to improve prediction and clinical utility.

Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women.

Although placental α microglobulin-1 performed the same as fetal fibronectin in ruling out spontaneous preterm delivery among symptomatic women, it demonstrated statistical superiority in predicting it.

Prediction of preterm birth using PAMG-1 test: a single centre experience - preliminary report.

PAMG-1 is a more accurate predictor of PTB when compared to CL, and routine use of both mentioned tests could allow identification of low-risk patients and reduction of rate of unnecessary hospitalizations and treatments.

Placental alpha microglobulin-1 (PartoSure) test for the prediction of preterm birth: a systematic review and meta-analysis

  • R. PirjaniA. Moini M. Sepidarkish
  • Medicine
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2019
Cervical PAMG-1 had a high accuracy to predict preterm birth within 7 and 14 d of testing in symptomatic pregnant women.

Comparison of PAMG-1 and phIGFBP-1 Tests for the Prediction of Preterm Delivery in Patients with Preterm Labor

This study strongly suggests that the PAMG-1 test is more accurate for predicting imminent spontaneous preterm delivery as compared to phIGFBP-1, and can significantly reduce economic burden caused by unnecessary admission and treatment of patients suspected of preterm labor.

Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor

  • M. RaviMercy BeljorieKarim Medhat El Masry
  • Medicine
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2018
Compared with qfFN, the PAMG-1 test is a better predictor of spontaneous delivery within 7 d while maintaining a very high negative predictive value, and is an easy-to-use bedside test that provides rapid results.

Methods of detection and prevention of preterm labour and the PAMG-1 detection test: a review

The use of PAMG-1 may make it possible to target the women at risk with a shortened cervix on ultrasound those with an imminent preterm delivery and therefore to adapt management, especially the administration of antenatal corticosteroid therapy.

References

SHOWING 1-10 OF 19 REFERENCES

Measurement of Placental Alpha-Microglobulin-1 in Cervicovaginal Discharge to Diagnose Rupture of Membranes

Measurement of placental alpha-microglobulin-1 in cervicovaginal secretions is superior to conventional clinical assessment in the diagnosis of rupture of membranes.

Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour.

There may be a role for cervical IGFBP-1 test in the management of women presenting with suspected preterm labour and it may allow us to focus the authors' efforts on women who are more likely to have a preterm delivery and to avoid unnecessary treatment and to contain healthcare costs.

Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test.

Both pIGFBP-1 and fetal fibronectin tests are effective adjuvant bedside test kits for the prediction of preterm delivery in patients presenting with signs or symptoms of pre term labour.

Fetal fibronectin as a predictor of spontaneous preterm birth: a European perspective

  • M. ChandiramaniG. D. Di Renzo A. Shennan
  • Medicine
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2011
The European perspective on the use of fFN is described and ongoing European clinical studies, which are appropriately designed with meaningful endpoints, are described, which will undoubtedly facilitate a better understanding of test accuracy and cost-effectiveness within different populations.

The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes

  • Seung Mi LeeR. Romero B. Yoon
  • Medicine
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2012
A positive Amnisure test in patients with preterm labor and intact membranes is a risk factor for adverse pregnancy outcome, particularly in patients who underwent fetal fibronectin (fFN) tests.

The utility of fetal fibronectin in the prediction and prevention of spontaneous preterm birth.

The development of an assay to detect vaginal fetal fibronectin, along with the use of transvaginal ultrasonography to determine cervical length, has greatly increased the ability to identify patients at highest risk for spontaneous preterm birth.

Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth

  • G. D. Di RenzoL. C. Roura Y. Ville
  • Medicine
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2011
The guidelines for the management of spontaneous preterm labor also take into consideration the diagnostic marker insulin-like growth factor binding protein-1 (IGFBP-1) that I have worked with since the early 80s, but some errors and points that may be misleading are brought to the readers’ attention.

OC01.02: What measurements are needed to classify pregnancies of unknown location?

O/E LHR and Delta PI in the third trimester are both predictive parameters for neonatal survival and occurrence of severe PHT in CDH.

The clinical significance of a positive Amnisure test™ in women with term labor with intact membranes

  • S. M. LeeJoonHo Lee B. Yoon
  • Medicine
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2009
A positive Amnisure test™ is present in about one-third nulliparous women at term presenting in labor with intact membranes, and patients with a positive test had a shorter admission-to-delivery interval than those with a negative test.